See also this year's filing and all EDGAR filings for this company.
PDF Report 0000794172_2021_MERIDIAN_BIOSCIENCE_INC.pdf
Logs
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.3434006467793886, 'aggregate_val': 405261000, 'exp_sum': 617212000, 'exp_to_value': {'AssetsCurrent': 162190000, 'AssetsNoncurrent': 211951000, 'PropertyPlantAndEquipmentNet': 31120000, 'Goodwill': 197383000, 'remainder_Assets': 14568000}} |
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 0.02356351743105627, 'aggregate_val': 157632000, 'exp_sum': 161436000, 'exp_to_value': {'LiabilitiesNoncurrent': 105108000, 'LiabilitiesCurrent': 56328000, 'remainder_Liabilities': 0}} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000794172, MERIDIAN BIOSCIENCE INC
xvar | xval | |
---|---|---|
0 | LiabilitiesNoncurrent | 105,108,000 |
1 | LiabilitiesCurrent | 56,328,000 |
2 | remainder_Liabilities | -3,804,000 |
3 | AssetsCurrent | 162,190,000 |
4 | AssetsNoncurrent | 211,951,000 |
5 | PropertyPlantAndEquipmentNet | 31,120,000 |
6 | Goodwill | 197,383,000 |
7 | remainder_Assets | -197,383,000 |
8 | GeneralAndAdministrativeExpense | 168,250,000 |
9 | ResearchAndDevelopmentExpense | 23,729,000 |
10 | remainder_Expenses | 13,471,000 |
11 | remainder_Revenues | 253,667,000 |
12 | remainder_NetIncome | -2,031,000 |
13 | remainder_ComprehensiveNetIncome | 3,115,000 |
yvar | yval | |
---|---|---|
0 | Liabilities | 157,632,000 |
1 | Assets | 405,261,000 |
2 | Expenses | 205,450,000 |
3 | Revenues | 253,667,000 |
4 | StockholdersEquity | 247,629,000 |
5 | NetIncome | 46,186,000 |
6 | ComprehensiveNetIncome | 47,743,500 |
7 | BaseVar | 513,578,000 |
8 | EconomicCapitalRatio | 0.918 |